T2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood

Science Translational Medicine

Volumn 5, Issue 182, 2013, Pages

  Neely, Lori A ^a   Audeh, Mark ^a   Phung, Nu Ai ^a   Min, Michael ^a   Suchocki, Adam ^a   Plourde, Daniella ^a   Blanco, Matthew ^a   Demas, Vasiliki ^a   Skewis, Lynell R ^a   Anagnostou, Theodora ^b   Coleman, Jeffrey J ^b,c   Wellman, Parris ^a   Mylonakis, Eleftherios ^b,c   Lowery, Thomas J ^a  

^a T2 Biosystems   (United States)

^b BROWN UNIVERSITY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; OLIGONUCLEOTIDE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ARTICLE; AUTOMATION; BLOOD ANALYSIS; BLOOD CULTURE; BLOOD SAMPLING; BLOODSTREAM INFECTION; CANDIDA; CANDIDEMIA; COLONY FORMING UNIT; CONTROLLED STUDY; DNA HYBRIDIZATION; FUNGAL DETECTION; HUMAN; HUMAN TISSUE; IMMUNOCOMPROMISED PATIENT; LIMIT OF DETECTION; MORTALITY; NUCLEAR MAGNETIC RESONANCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELAXOMETER; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SIGNAL PROCESSING; SPECIES IDENTIFICATION;

CANDIDA; CANDIDEMIA; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; NANOPARTICLES; POLYMERASE CHAIN REACTION;

EID: 84877777940     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3005377     Document Type: Article

References (39)

1. A. Kumar, P. Ellis, Y. Arabi, D. Roberts, B. Light, J. E. Parrillo, P.Dodek, G.Wood,D. Simon, C. Peters, M. Ahsan, D. Chateau; Cooperative Antimicrobial Therapy of Septic Shock Database Research Group, Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 136, 1237-1248 (2009).
2. M. Morrell, V. J. Fraser, M. H. Kollef, Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: A potential risk factor for hospital mortality. Antimicrob. Agents Chemother. 49, 3640-3645 (2005).
3. K. W. Garey, M. Rege, M. P. Pai, D. E. Mingo, K. J. Suda, R. S. Turpin, D. T. Bearden, Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multiinstitutional study. Clin. Infect. Dis. 43, 25-31 (2006).
4. E. K. Spanakis, G. Aperis, E. Mylonakis, New agents for the treatment of fungal infections: Clinical efficacy and gaps in coverage. Clin. Infect. Dis. 43, 1060-1068 (2006).
5. A. N. Ellepola, C. J. Morrison, Laboratory diagnosis of invasive candidiasis. J. Microbiol. 43 Spec. No., 65-84 (2005).
6. A. Lau, T. C. Sorrell, S. Chen, K. Stanley, J. Iredell, C. Halliday, Multiplex tandem PCR: A novel platform for rapid detection and identification of fungal pathogens from blood culture specimens. J. Clin. Microbiol. 46, 3021-3027 (2008).
7. T. De Baere, G. Claeys, D. Swinne, G. Verschraegen, A. Muylaert, C. Massonet, M. Vaneechoutte, Identification of cultured isolates of clinically important yeast species using fluorescent fragment length analysis of the amplified internally transcribed rRNA spacer 2 region. BMC Microbiol. 2, 21 (2002).
8. C. Dierkes, B. Ehrenstein, S. Siebig, H. J. Linde, U. Reischl, B. Salzberger, Clinical impact of a commercially available multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis. BMC Infect. Dis. 9, 126 (2009).
9. H. Einsele, H. Hebart, G. Roller, J. Löffler, I. Rothenhofer, C. A. Müller, R. A. Bowden, J. van Burik, D. Engelhard, L. Kanz, U. Schumacher, Detection and identification of fungal pathogens in blood by using molecular probes. J. Clin. Microbiol. 35, 1353-1360 (1997).
10. P. D. Khot, D. N. Fredricks, PCR-based diagnosis of human fungal infections. Expert Rev. Anti Infect. Ther. 7, 1201-1221 (2009).
11. J. B. Haun, C. M. Castro, R. Wang, V. M. Peterson, B. S. Marinelli, H. Lee, R. Weissleder, Micro- NMR for rapid molecular analysis of human tumor samples. Sci. Transl. Med. 3, 71ra16 (2011).
12. T. Lowery, Nanomaterials-Based Magnetic Relaxation Switch Biosensors (Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, 2009).
13. H. Lee, T. J. Yoon, J. L. Figueiredo, F. K. Swirski, R. Weissleder, Rapid detection and profiling of cancer cells in fine-needle aspirates. Proc. Natl. Acad. Sci. U.S.A. 106, 12459-12464 (2009).
14. S. S. Agasti, M. Liong, C. Tassa, H. J. Chung, S. Y. Shaw, H. Lee, R. Weissleder, Supramolecular host-guest interaction for labeling and detection of cellular biomarkers. Angew. Chem. Int. Ed. Engl. 51, 450-454 (2012).
15. J. B. Haun, T. J. Yoon, H. Lee, R. Weissleder, Magnetic nanoparticle biosensors. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2, 291-304 (2010).
16. I. Koh, R. Hong, R. Weissleder, L. Josephson, Nanoparticle-target interactions parallel antibody- protein interactions. Anal. Chem. 81, 3618-3622 (2009).
17. L. L. Horvath, D. R. Hospenthal, C. K. Murray, D. P. Dooley, Detection of simulated candidemia by the BACTEC 9240 system with Plus Aerobic/F and Anaerobic/F blood culture bottles. J. Clin. Microbiol. 41, 4714-4717 (2003).
18. B. J. George, L. L. Horvath, D. R. Hospenthal, Effect of inoculum size on detection of Candida growth by the BACTEC 9240 automated blood culture system using aerobic and anaerobic media. J. Clin. Microbiol. 43, 433-435 (2005).
19. L. L. Horvath, B. J. George, D. R. Hospenthal, Detection of fifteen species of Candida in an automated blood culture system. J. Clin. Microbiol. 45, 3062-3064 (2007).
20. D. P. Manage, Y. C. Morrissey, A. J. Stickel, J. Lauzon, A. Atrazhev, J. P. Acker, L. M. Pilarski, On-chip PCR amplification of genomic and viral templates in unprocessed whole blood. Microfluid. Nanofluid. 10, 697-702 (2011).
21. M. B. Kermekchiev, L. I. Kirilova, E. E. Vail, W. M. Barnes, Mutants of Taq DNA polymerase resistant to PCR inhibitors allow DNA amplification from whole blood and crude soil samples. Nucleic Acids Res. 37, e40 (2009).
22. Y. Bu, H. Huang, G. Zhou, Direct polymerase chain reaction (PCR) from human whole blood and filter-paper-dried blood by using a PCR buffer with a higher pH. Anal. Biochem. 375, 370-372 (2008).
23. M. Panaccio, M. Georgesz, A. M. Lew, FoLT PCR: A simple PCR protocol for amplifying DNA directly from whole blood. Biotechniques 14, 238-243 (1993).
24. J. McCusker, M. T. Dawson, D. Noone, F. Gannon, T. Smith, Improved method for direct PCR amplification from whole blood. Nucleic Acids Res. 20, 6747 (1992).
25. H. Mirhendi, B. Bruun, H. C. Schonheyder, J. J. Christensen, K. Fuursted, B. Gahrn-Hansen, H. K. Johansen, L. Nielsen, J. D. Knudsen, M. C. Arendrup, Differentiation of Candida glabrata, C. nivariensis and C. bracarensis based on fragment length polymorphism of ITS1 and ITS2 and restriction fragment length polymorphism of ITS and D1/D2 regions in rDNA. Eur. J. Clin. Microbiol. Infect. Dis. 30, 1409-1416 (2011).
26. M. M. Díaz-López, O. A. Oliveros-Garay, O. Orozco-Diaz, SSCP analysis (ITS2, ERG11) in clinical Candida isolates from oral cavity in oncology patients. Rev. Iberoam. Micol. 21, 182-186 (2004).
27. L. Josephson, J. M. Perez, R. Weissleder, Magnetic nanosensors for the detection of oligonucleotide sequences. Angew. Chem. 113, 3304-3306 (2001).
28. V. Demas, T. J. Lowery, Magnetic resonance for in vitro medical diagnostics: Superparamagnetic nanoparticle-based magnetic relaxation switches. New J. Phys. 13, 025005 (2011).
29. A. A. Kulkarni, A. A. Weiss, S. S. Iyer, Detection of carbohydrate binding proteins using magnetic relaxation switches. Anal. Chem. 82, 7430-7435 (2010).
30. P. G. Pappas, J. H. Rex, J. D. Sobel, S. G. Filler, W. E. Dismukes, T. J. Walsh, J. E. Edwards; Infectious Diseases Society of America, Guidelines for treatment of candidiasis. Clin. Infect. Dis. 38, 161-189 (2004).
31. L. M. Vanhee, W. Meersseman, K. Lagrou, J. Maertens, H. J. Nelis, T. Coenye, Rapid and direct quantification of viable Candida species in whole blood by use of immunomagnetic separation and solid-phase cytometry. J. Clin. Microbiol. 48, 1126-1131 (2010).
32. K. H. Rand, H. Houck, M. Wolff, Detection of candidemia by polymerase chain reaction. Mol. Cell. Probes 8, 215-221 (1994).
33. M. A. Pfaller, D. J. Diekema, Epidemiology of invasive candidiasis: A persistent public health problem. Clin. Microbiol. Rev. 20, 133-163 (2007).
34. A. S. Orozco, L. M. Higginbotham, C. A. Hitchcock, T. Parkinson, D. Falconer, A. S. Ibrahim, M. A. Ghannoum, S. G. Filler, Mechanism of fluconazole resistance in Candida krusei. Antimicrob. Agents Chemother. 42, 2645-2649 (1998).
35. P. G. Pappas, C. A. Kauffman, D. Andes, D. K. Benjamin Jr., T. F. Calandra, J. E. Edwards Jr., S. G. Filler, J. F. Fisher, B. J. Kullberg, L. Ostrosky-Zeichner, A. C. Reboli, J. H. Rex, T. J. Walsh, J. D. Sobel; Infectious Diseases Society of America, Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 48, 503-535 (2009).
36. I. Koh, R. Hong, R. Weissleder, L. Josephson, Sensitive NMR sensors detect antibodies to influenza. Angew. Chem. Int. Ed. Engl. 47, 4119-4121 (2008).
37. K. C. Ha, T. C. White, Effects of azole antifungal drugs on the transition from yeast cells to hyphae in susceptible and resistant isolates of the pathogenic yeast Candida albicans. Antimicrob. Agents Chemother. 43, 763-768 (1999).
38. P. Josefson, K. Strålin, A. Ohlin, T. Ennefors, B. Dragsten, L. Andersson, H. Fredlund, P. Mölling, P. Olcén, Evaluation of a commercial multiplex PCR test (SeptiFast) in the etiological diagnosis of community-onset bloodstream infections. Eur. J. Clin. Microbiol. Infect. Dis. 30, 1127-1134 (2011).
39. P. M. Dark, P. Dean, G. Warhurst, Bench-to-bedside review: The promise of rapid infection diagnosis during sepsis using polymerase chain reaction-based pathogen detection. Crit. Care 13, 217 (2009).